Company
Invus
Investments
| Company | Round | Date | Lead |
|---|---|---|---|
| Lycia Therapeutics | Series D | 2026-06-29 | |
| City Therapeutics, Inc. | Series B | 2026-06-09 | |
| Flexiv | Funding | 2026-03-19 | Lead |
| Corxel Pharmaceuticals | Series D | 2026-01-26 | |
| Triana Biomedicines | Series B | 2025-12-03 | |
| Antares Therapeutics | Series A | 2025-06-11 | |
| Bambusa Therapeutics | Series A | 2025-02-18 | |
| City Therapeutics, Inc. | Series A Funding | 2024-10-08 | |
| Triveni Bio | Series B Funding | 2024-10-02 | |
| Cardurion Pharmaceuticals | Series B Financing | 2024-07-16 | Lead |
| Scorpion Therapeutics | Series C Financing | 2024-07-16 | Lead |
| Endeavor BioMedicines, Inc | Series C Funding | 2024-04-24 | |
| Alterome Therapeutics | Series B Funding | 2024-04-08 | |
| Triveni Bio | Series A | 2023-10-26 | |
| PayJoy | Capital Raise | 2023-09-06 | |
| ADARx Pharmaceuticals | Series C Financing | 2023-08-10 | |
| Septerna | Series B Financing | 2023-07-17 | |
| Convergent Therapeutics | Series A Funding | 2023-05-03 | |
| Ring Therapeutics | Series C Funding | 2023-03-09 | Lead |
| Bicara Therapeutics | Series B Financing | 2023-03-06 | |
| Neumora Therapeutics | Series B | 2022-10-11 | Lead |